Expression of Erythroid Differentiation Regulator 1 (Erdr1) in Vitiligo

Erythroid Differentiation Regulator 1 (Erdr1) Cytokine Clinical Trial

Official title:

Expression of Erythroid Differentiation Regulator 1 (Erdr1) Cytokine in the Vitiliginous Skin Lesions: a Case Control Study

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03377998
• Other study ID #: Dermatology 4
• Status: Not yet recruiting
• Phase: N/A
• First received: December 11, 2017
• Last updated: December 14, 2017
• Start date: January 2018
• Est. completion date: July 2018

Study information

• Verified date: December 2017
• Source: Cairo University
• Contact: Maha Fathy Elmasry, MD
• Phone: 00201222633740
• Email: mahafathy1214[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Expression of Erythroid differentiation regulator 1 (Erdr1) cytokine in vitiligo

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 100
• Est. completion date: July 2018
• Est. primary completion date: July 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients with generalized non-segmental vitiligo.

• Both sexes.

• Age >18 years old.

• New cases or cases not receiving any medication for at least 3 months ago.

Exclusion Criteria:

• Segmental or Universal vitiligo

• Autoimmune diseases

Related Conditions & MeSH terms

• Erythroid Differentiation Regulator 1 (Erdr1) Cytokine

Intervention

Other:
• skin biopsy
Skin biopsy for measuring tissue levels of the Erythroid differentiation regulator 1 (Erdr1) cytokine will be taken from the lesional skin of patients of vitiligo and from normal skin of healthy controls.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Expression of tissue levels of erythroid differentiation regulator 1 (Erdr1) cytokine in patients of vitiligo	Expression of tissue levels of erythroid differentiation regulator 1 (Erdr1) cytokine in patients of vitiligo and comparing its level in normal subjects	6 months